tiprankstipranks
Pressure Biosciences (PBIO)
OTHER OTC:PBIO
US Market

Pressure Biosciences (PBIO) Financial Statements

55 Followers

Pressure Biosciences Financial Overview

Pressure Biosciences's market cap is currently ―. The company's EPS TTM is $-1.691; its P/E ratio is -0.09; Pressure Biosciences is scheduled to report earnings on April 16, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 512.00K$ 741.00K$ 607.00K$ 144.03K$ 498.14K
Gross Profit$ 255.40K$ 1.10M$ -664.30K$ 17.83K$ 196.00K
EBIT$ -1.04M$ 5.13M$ -1.53M$ -2.43M$ -1.08M
EBITDA$ 195.50K$ 5.78M$ -1.47M$ -2.42M$ -1.05M
Net Income Common Stockholders$ -11.11M$ 1.47M$ -4.89M$ -4.89M$ -3.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 24.98K$ 239.02K$ 3.87K$ 230.88K$ 121.57K
Total Assets$ 1.68M$ 2.21M$ 2.01M$ 2.84M$ 2.89M
Total Debt$ 18.78M$ 19.25M$ 19.89M$ 19.29M$ 18.08M
Net Debt$ 18.76M$ 19.01M$ 19.89M$ 19.06M$ 17.96M
Total Liabilities$ 26.79M$ 34.66M$ 34.70M$ 32.62M$ 30.10M
Stockholders Equity$ -25.12M$ -32.45M$ -32.69M$ -29.78M$ -27.21M
Cash Flow-
Free Cash Flow$ -899.17K$ -425.21K$ -1.43M$ -1.07M$ -1.25M
Operating Cash Flow$ -899.17K$ -422.21K$ -1.43M$ -1.05M$ -1.24M
Investing Cash Flow-$ -3.00K$ -1.00$ -15.86K$ -3.75K
Financing Cash Flow$ 685.13K$ 660.37K$ 1.20M$ 1.18M$ 1.25M
Currency in USD

Pressure Biosciences Earnings and Revenue History

Pressure Biosciences Debt to Assets

Pressure Biosciences Cash Flow

Pressure Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis